Examination of Barrett’s esophagus
barrett
barrett
PPI, Aspirin and Prevention of Barrett’s Neoplasia – How Do We Treat Our Barrett Patients Now?
Almost everybody prescribes at least low-dose PPI to their Barrett patients even if they complete asymptomatic – is this warranted?
Paris Classification: Early Barrett Cancers
In the following, examples for superficial/early Barrett lesions of the esophagus are shown. Here, flat and sessilelesions are predominant, pedunculated tumors are rare. Sessile tumor
Prague Classification Barrett Esophagus
The Prague classification was presented by an international research group in 2006 (1) and has since been regarded as the standard for measuring the length
Early esophageal carcinoma (squamous epithelium): tips and tricks for difficult ESDs
Early esophageal carcinoma (squamous epithelium): tips and tricks for difficult ESDs
Endoscopic examination of a normal Z-line
Visualization of the Z-line without enhancement and with iScan, obstructed by esophageal motility.
Risk stratification in Barrett’s esophagus — the emperor’s new clothes?
The efficacy of surveillance for Barrett’s patients is a matter of controversy, and it is probably due to the low long-term risk of carcinoma developing
Low-grade dysplasia in Barrett’s esophagus — a second opinion is important, but then treatment is needed
Low-grade dysplasia (low-grade intraepithelial neoplasia, LGIN) is difficult to distinguish from inflammation histopathologically. The interobserver variance rates usually show kappa values below 0.4, representing a
Does Barrett’s esophagus grow during monitoring?
The risk of progression of nonneoplastic Barrett’s esophagus to high-grade intraepithelial neoplasia or adenocarcinoma is extremely low and has been reported in recent studies to
